These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9086793)

  • 1. [New approach for the absorbent therapy of verotoxin-producing Escherichia coli infection].
    Takeda T; Yoshino K; Matsuda E
    Nihon Rinsho; 1997 Mar; 55(3):751-7. PubMed ID: 9086793
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects for preventing serious systemic toxemic complications of Shiga toxin-producing Escherichia coli infections using Shiga toxin receptor analogues.
    Karmali MA
    J Infect Dis; 2004 Feb; 189(3):355-9. PubMed ID: 14745691
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Escherichia coli verotoxin (relationship between verotoxin produced by E. coli O157: H7 and HUS)].
    Matsunaga T; Komoda T
    Nihon Rinsho; 1999 Nov; 57 Suppl():172-5. PubMed ID: 10635805
    [No Abstract]   [Full Text] [Related]  

  • 5. [Verotoxin induced hemolytic uremic syndrome: pathophysiology of neurological involvement].
    Takagi C; Naruse T
    Nihon Rinsho; 1997 Mar; 55(3):731-5. PubMed ID: 9086789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and molecular biology of verotoxin produced by enterohemorrhagic Escherichia coli].
    Iijima Y; Honda T
    Nihon Rinsho; 1997 Mar; 55(3):646-50. PubMed ID: 9086774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictive indicators for progression to severe complications(hemolytic-uremic syndrome and encephalopathy) and their prevention in enterohemorrhagic Escherichia coli infection].
    Joh K
    Nihon Rinsho; 1997 Mar; 55(3):700-5. PubMed ID: 9086784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin].
    Nishikawa K
    Tanpakushitsu Kakusan Koso; 2008 Jan; 53(1):44-51. PubMed ID: 18186302
    [No Abstract]   [Full Text] [Related]  

  • 9. Outbreak of Vero cytotoxin producing Escherichia coli O157 infection in Dorset.
    Commun Dis Rep CDR Wkly; 1998 May; 8(21):183, 186. PubMed ID: 9635343
    [No Abstract]   [Full Text] [Related]  

  • 10. [An old female case of vero-cytotoxin-producing Escherichia coli O-157: H7 infection].
    Takaki Y; Makishita A; Goto M; Motomatsu T; Yoshihara T
    Fukuoka Igaku Zasshi; 1997 Apr; 88(4):128-31. PubMed ID: 9154716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Properties of Vero toxin produced by pathogenic E. coli O157 (enterohemorrhagic E. coli)].
    Kurasono H; Hayashi E
    J Toxicol Sci; 1996 Aug; 21(3 Appendix):151-9. PubMed ID: 8965332
    [No Abstract]   [Full Text] [Related]  

  • 12. [New drugs that prevent cytotoxicity of Shiga toxins].
    Natori Y
    Nihon Rinsho; 2002 Jun; 60(6):1131-7. PubMed ID: 12078085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outbreak of Vero cytotoxin producing Escherichia coli O157 infection in north Cumbria.
    Commun Dis Rep CDR Wkly; 1999 Mar; 9(11):95, 98. PubMed ID: 10205976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detection of verotoxin genes in verotoxin-producing Escherichia coli by polymerase chain reaction and their genotyping].
    Ito K; Matsuzaki M
    Nihon Rinsho; 1997 Mar; 55(3):660-4. PubMed ID: 9086777
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
    Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotypes and virulence markers of Shiga toxin-producing Escherichia coli (STEC) isolated from dairy cattle in São Paulo State, Brazil.
    Irino K; Kato MA; Vaz TM; Ramos II; Souza MA; Cruz AS; Gomes TA; Vieira MA; Guth BE
    Vet Microbiol; 2005 Jan; 105(1):29-36. PubMed ID: 15607081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Enterohemorrhagic Escherichia coli infection].
    Nakayama K; Sato T
    Nihon Rinsho; 2004 May; 62 Suppl 5():472-7. PubMed ID: 15197966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis of enterohaemorrhagic Escherichia coli by the detection of vero toxin (or Shiga toxin)].
    Yamasaki S; Takeda Y
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 1999; 10(1):51-7. PubMed ID: 10651523
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of a Shiga-toxin type I variant containing an IS1203-like element, from Shiga-toxin producing Escherichia coli O157:H7.
    Suzuki M; Kondo F; Ito Y; Matsumoto M; Hata M; Oka H; Takahashi M; Sakae K
    FEMS Microbiol Lett; 2004 May; 234(1):63-7. PubMed ID: 15109720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between hemolytic uremic syndrome and verotoxin-producing strains of E. coli.
    Jure MA; de Saab OA; de Castillo MC; Sesma F; Miceli S; Zamora AM; de Ruiz Holgado AP; de Nader OM
    Rev Latinoam Microbiol; 1998; 40(1-2):1-8. PubMed ID: 10932728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.